Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
The second part is "Painting the Tape".
This has been so obvious also. I'm a non-technician and have seen is clear as day.
Linda Powers said "buy Low" in it's complaint against market manipulators. LOL. LOL.
$nwbo lawsuit filed pic.twitter.com/VsNz9jkBwM
— JohnWarner (@JohnWarner1970) December 1, 2022
Sorry for the short sellers that LP is not Geert.
He's Paid. LOL Dr.Wen Disclosures
Patrick Wen, MD, is a member of the Speaker’s Bureau for Merck and Prime Oncology.
Patrick Wen, MD, serves as a consultant/advisory board member for Agios, Astra Zeneca, Bayer, Blue Earth Diagnostics, Immunomic Therapeutics, Karyopharm, Kiyatec, Puma, Taiho, Vascular Biogenics, Deciphera, and VBI Vaccines.
Patrick Wen, MD, received research support from Agios, Astra Zeneca, Bayer, Blue Earth Diagnostics, Immunomic Therapeutics, Karyopharm, Kiyatec, Puma, Taiho, Vascular Biogenics, Deciphera, and VBI Vaccines.
The low news coverage is simply because it is a rare disease. Despite some high profile deaths, it is not breast cancer that affects millions in the US.
When we get some fresh, current solid tumor data, that will be a big story. IMHO.
ZZZZZZZZZZZZ...We don't agree. I don't know who 'many' is. Not me. Not you.
Fidelity has "limited margin" on IRA's, but i am not sure if shares get lent out.
https://www.fidelity.com/learning-center/trading-investing/trading/limited-margin-trading-IRA#:~:text=Limited%20margin%20is%20available%20for,a%20limited%20margin%20account%20supplement.
LP must Stay I Vote YES
Please keep company
Scotty..company value is UP. Market cap is a great measurement.
November 25, 2022 $942.30M
November 26, 2021 $751.50M
This market cap increase is about 25%. Not bad for a year. So, despite dilution for operating costs, the market has responded well to the news of the trial and journal.
AF writes for a Niche Market.
$NWBO Adam Feuerstein serves a "Niche Market" of journalism. pic.twitter.com/G4s78Zl0Qt
— LearningEveryTrade 🚀📈💰 (@EveryTrade) November 28, 2022
freethink article, got some issues... https://www.freethink.com/health/brain-cancer-vaccine
The website ALS TDI defines "Post-Hoc" analysis as this "The act of looking at the data from a trial or other experiment in new ways after the study’s conclusion is called “post-hoc analysis.”
The Endpoint change was in the works well before the trial concluded, thus, Post-Hoc analysis impossible to be considered as to why endpoint was changed.
post-hoc is often used to create new trials based on subgroups found after a trial concludes.
LutherBlissett, Each C share converts to 25 shares, so, it's not like they are multiply the vote by 25, but is actually 25 shares voting.
I think the time/date will change. They have a few weeks to do that if they need.
ASM during trading hours is unusual. IMHO.
Edit: "unusual for most companies", and we are certainly not most companies. Which for me, is a good thing.
iHub is getting fancy! The "Read 2 replies" is actually clickable. Neat!$NWBO
— hoffmann6383 (@hoffmann6383) November 25, 2022
What is the difference between "Preliminary" proxy filed today versus the "Definitive" proxy filed in all prior years?
I think Cofer Black picked the date....lol lol...
4 Million shares were not borrowed 11/22 for no reason.
Yes, as expected, given the 'C' shares, need breathing room. Not going BK....sorry shorts.
https://smithonstocks.com/why-i-believe-northwest-biotherapeutics-has-been-and-continues-to-be-the-subject-of-a-powerful-stock-manipulation-scheme/
Thanks iwasadvier for the find.
$NWBO I think we have a squeeze coming that will be epic. I believe also that whatever cards management is holding will be put on the table before December 6th. Let’s see what happens…https://t.co/iwZWMdHIzy
— Gregory Zivic, MD (@metacollectiveG) November 25, 2022
Was posted a month or so ago, too. it's just a data crawler pulling the "est trial completion" data from ct.gov. Which has been unchanged since May 2022.
Agree! The people connecting professional courtesy postings to meaning a buyout, no wonder the shorts salivate. Oh, snap, it's probably traders posting to froth up the price. Yes, that is probably it. IMHO.
This is what SEC investigations are made of. Thanks Sky.
I agree with you. Since Optune is a device, why not? I would love to see trials. No harm, no foul. I think those pitting NWBO vs. NVCR and calling for NVCR stock to plummet just might be trying to sell put options for income, when they actually feel the stock price is going to be fine. NVCR is getting in tight with government leaders and opening offices in many countries. It's about patients and anything to help their lives.
IMHO.
I'm thinking that Friday, a Bear raid would make sense, everyone traveling home, not paying attention, food coma.
Of course, if something is predictable days out, that shows collusion, premeditation, etc..
Perhaps a small dip at the close, to lite the fuse, send a smoke signal, so to speak.
Either way, I have dry powder ready. I have been holding it since the SNO date was announced, and was also Thanksgiving week. I am Thankful !!
Feel free to reach out to DI
CONTACTS
Dave Innes
804-513-4758
dinnes@nwbio.com
source, https://nwbio.com/
he won't answer. LOL. I have asked to define "expert" and am still waiting. LOL.
The huge drop in Borrowable shares, from 4,400,000 to 6,000.
Which is more likely, the have been borrowed, to short OR large shareholder has removed them from being able to be borrowed?
https://iborrowdesk.com/report/NWBO
https://fintel.io/ss/us/nwbo
who doubts it, beside you? LOL
who doubts it? LOL
I don't think anyone who matters if affected by AF at all. His M.O. is trials. Any changes to them, for whatever reason, makes them a target, the smaller the company, the softer the target. Kinda of like midwest saying why punch Mike Tyson when you can kick a Granny in the shins. Much easier.
KHN simply got feed same way AACR did. Same way Universities and Hospitals got our positive story. Just a news feed, no judgement on veracity.
What about this paper... 2019 Dr.Cloughey ECT's.
https://aacrjournals.org/clincancerres/article/25/16/4993/125037/Design-and-Evaluation-of-an-External-Control-Arm
of course he did not, he was not in the job position then. LOL.
Musella LL Webinar Change
$NWBO Al Musella Webinar with Dr. Linda Liau has changed date/time. Now Dec 5th, 8:30 PM EST.https://t.co/2BeU0VF2tz
— LearningEveryTrade 🚀📈💰 (@EveryTrade) November 22, 2022
like who?
Ok, the bear is cute. had not seen it yet.
She sounds smart, so she would probably recommend against getting investment advice from a chat room.
(Sorry bearish sentiment, wanted to see what it looked like with a one liner poster.)
leukemia is not a 'tumor' cancer. So, Apple Juice to Orange Juice..fresh squeezed.
pattyloco see image here for pseudoprogression explained.
For Immunotherapy, look at 3-months, it looks like the tumor is on a terror... but look at 6-month, what?? how is this possible, at 3 months, the PFS looked awful. That 3-month image is full of immune system response. Making the mass look larger.
With mid 2010's imaging, and half the independent radiologist being wrong on their 'progression' diagnosis, PFS just cannot be used as an endpoint in immunotherapy. The imaging is better now thankfully. Did some placebo/SOC pseudoprogressors get crossover DCVAX? Possibly, hence the sticky point of this. IMHO.
"A" Always Supporting Management. ASM.